Jinhe Biotechnology Co.Ltd(002688)
Annual report for 2021
April 2022
Section I important tips, contents and definitions
The board of directors, the board of supervisors and the directors, supervisors and senior managers of the company guarantee that the contents of the annual report are true, accurate and complete without false records, misleading statements or major omissions, and bear individual and joint legal liabilities.
Wang Dongxiao, the person in charge of the company, Niu Youshan, the person in charge of accounting, and Zhou Lihang, the person in charge of the accounting organization (Accounting Supervisor), declare that they guarantee the authenticity, accuracy and completeness of the financial report in this annual report.
All directors have attended the meeting of the board of directors to consider this report.
1. Risks of rising prices of raw materials and energy
The raw material of the company's main product aureomycin is corn starch, which accounts for a large proportion of the cost of aureomycin. The rise of corn price has a great impact on the cost of aureomycin products of the company. At the same time, the sharp rise in coal prices will also increase the production cost of the company's chemical products and reduce the profit margin of the products.
2. Exchange rate risk
The company's assets denominated in US dollars and the company's overseas sales revenue are related to exchange rate fluctuations, so exchange rate fluctuations will affect the company's performance.
3. Market risk
Affected by the pig cycle, the breeding industry continues to be depressed. As an upstream industry of the breeding industry, the company's animal insurance business is bound to be affected by it. Therefore, there is a risk that the market does not meet expectations.
4. R & D risk
The company continues to invest in vaccine product research and development. Vaccine product research and development cycle is long, investment is large, technology is complex, and there is a risk of uncertainty in the research and development results.
The company's profit distribution plan reviewed and approved by the board of directors is: take 780422398 as the base, distribute cash dividend of 0.00 yuan (tax included) to all shareholders for every 10 shares, send bonus shares of 0 share (tax included), and do not use the accumulation fund to increase the share capital.
catalogue
Section I important tips, contents and definitions Section 2 company profile and main financial indicators Section III discussion with management Section IV corporate governance 48 Section V environmental and social responsibility 73 section VI important matters 79 Section VII changes in shares and shareholders Section VIII preferred shares 103 section IX relevant information of bonds 104 section x financial report one hundred and five
Directory of documents for future reference
1、 The original of the 2021 annual report signed and confirmed by the directors, supervisors and senior managers of the company. 2、 Financial statements containing the signatures and seals of the person in charge of the company, the person in charge of accounting work and the person in charge of accounting organization (Accounting Supervisor). 3、 The original of the audit report with the seal of ShineWing Certified Public Accountants (special general partnership) and the signature and seal of the certified public accountant. 4、 The originals of all company documents and announcements publicly disclosed on the website designated by the CSRC during the reporting period. 5、 The place where the above documents for future reference are prepared: the Securities Department of the company and Shenzhen Stock Exchange.
interpretation
Explanatory item refers to the explanatory content
The company, the company, the joint stock company, Jinhe Biotechnology Co.Ltd(002688) refers to Jinhe Biotechnology Co.Ltd(002688)
Jinhe holding refers to Inner Mongolia Jinhe Holding Co., Ltd
Jian'an company and Jinhe Jian'an refer to Inner Mongolia Jinhe construction and installation Co., Ltd
Starch company and Jinhe starch refer to Inner Mongolia Jinhe Starch Co., Ltd
Animal pharmaceutical and Jinhe animal pharmaceutical refer to Inner Mongolia Jinhe Animal Pharmaceutical Co., Ltd
Jinhe pharmaceutical refers to Inner Mongolia Jinhe Pharmaceutical Technology Co., Ltd
Jinhe environmental protection and environmental protection company refers to Inner Mongolia Jinhe Environmental Protection Technology Co., Ltd
Jinhe Youben company refers to Jinhe Youben Biological Products Co., Ltd
Farmaway means farmgate Inc
Hangzhou Youben refers to Hangzhou Youben animal vaccine Co., Ltd
Hohhot Youben vaccine technology Co., Ltd
Putek, famavir biological products and biologics refer to protatek international, Inc., famavir Jinyu Bio-Technology Co.Ltd(600201) Co., Ltd., pharmgate Inc. biologics Inc. and protatek International Biologics Inc.
Animal nutrition company refers to Inner Mongolia Jinhe Animal Nutrition Technology Co., Ltd
Muxing Chongqing refers to Jinhe muxing (Chongqing) Biotechnology Co., Ltd
Jining environmental protection refers to Jining Jinhe Environmental Protection Technology Co., Ltd
Kodiago means coldiagro
Solid waste disposal refers to Tuoketuo Jinhe environmental protection solid waste disposal Co., Ltd
Liangshan Ruyi refers to Liangshan Ruyi Yellow River Beach sewage treatment Co., Ltd
Zhaqi water and Jinhe water refer to zhalai banner Jinhe water Co., Ltd
Jinhe reclaimed water company refers to Tuoketuo Jinhe environmental protection reclaimed water resources Co., Ltd
Penfield refers to Penfield oil company
CSRC refers to the China Securities Regulatory Commission
Shenzhen stock exchange refers to Shenzhen Stock Exchange
A share refers to RMB ordinary shares
Company Law refers to the company law of the people's Republic of China
Securities Law refers to the securities law of the people's Republic of China
The articles of association refers to the Jinhe Biotechnology Co.Ltd(002688) articles of association
GMP refers to the good manufacturing practice
FDA refers to the abbreviation of U.S. Food and drug administration, namely the U.S. Food and drug administration
The reporting period refers to 2021
Section II Company Profile and main financial indicators
1、 Company information
Stock abbreviation Jinhe Biotechnology Co.Ltd(002688) stock code Jinhe Biotechnology Co.Ltd(002688)
Shenzhen Stock Exchange
Chinese name of the company Jinhe Biotechnology Co.Ltd(002688)
Chinese abbreviation of the company Jinhe Biotechnology Co.Ltd(002688)
Foreign language name of the company (if any) Jinhe Biotechnology Co., Ltd
Abbreviation of the company's foreign name (e.g
Yes) Jinhe Biotechnology
Legal representative of the company: Wang Dongxiao
Registered address: No. 71, Xinping Road, Tuoketuo County, Inner Mongolia Autonomous Region
Postal code of registered address 010200
Historical change of registered address of the company
nothing
condition
Office address: No. 71, Xinping Road, Tuoketuo County, Inner Mongolia Autonomous Region
Postal code of office address 010200
Company website: www.jinhe.com com. cn.
E-mail [email protected].
2、 Contact person and contact information
Secretary of the board of directors and securities affairs representative
Name has a long way to go
Contact address: 84 Xing'an North Road, Xincheng District, Hohhot, Inner Mongolia
22 / F, dingshenghua Century Plaza office building
Tel: 04713291630
Fax 04713291625
E-mail [email protected].
3、 Information disclosure and preparation location
The website of the stock exchange on which the company discloses the annual report includes Securities Daily, securities times, China Securities News and Shanghai Securities News
Media name and website of the annual report disclosed by the company http://www.cn.info.com.cn.
The company's annual report is prepared at the company's securities department and Shenzhen Stock Exchange
4、 Registration changes
Organization code unified social credit code 9115 Shenzhen Properties & Resources Development (Group) Ltd(000011) 4368372k
Changes in the company's main business since its listing (for example, in 2015, the company added a new business scope: production of additive premixed feed (vitamin premixed feed) (livestock, poultry and aquatic products, ruminants, pets and special animals); In 2018, the company added a new business scope: the production of oxytetracycline calcium premix, feed raw materials and mixed feed additives.
Changes of previous controlling shareholders (if any) on July 16, 2021, the controlling shareholder of the company was changed from Jinhe Jian'an to Jinhe holding.
5、 Other relevant information: accounting firm employed by the company
Name of accounting firm: ShineWing Certified Public Accountants (special general partnership)
Office address of the accounting firm: 8 / F, building a, Fuhua building, No. 8, Chaoyangmen North Street, Dongcheng District, Beijing
Name of signature accountant: Zhai Xiaomin, Shi Zhouhong
Recommendation agencies hired by the company to perform continuous supervision duties during the reporting period √ applicable □ not applicable
Name of recommendation institution office address of recommendation institution name of recommendation representative during continuous supervision
Orient Securities Company Limited(600958) underwriting and recommendation Co., Ltd. Han Yang and Huang Jian, 318 south Zhongshan Road, Huangpu District, Shanghai August 2021 December 31, 2022, 24th floor
Those employed by the company to perform continuous supervision duties during the reporting period
